Related Experiment Video
Updated: Sep 9, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Racial Disparities in Cardiogenic Shock Outcomes: Single-Center Retrospective Study
Rafik I Issa1, Sarah K Adie2, Vince D Marshall3
1Rafik I. Issa is an internal medicine physician, Department of Internal Medicine, Michigan Medicine, Ann Arbor, Michigan.
Insights
Black patients with cardiogenic shock experienced longer hospital stays but similar mortality rates compared to White patients. This study highlights potential disparities in care for Black individuals experiencing cardiogenic shock.
Area of Science:
- Cardiology
- Health Services Research
- Health Equity
Background:
- Race significantly impacts cardiovascular disease outcomes, but its effect on cardiogenic shock is not well understood.
- Understanding racial disparities in cardiogenic shock is crucial for equitable patient care.
Purpose of the Study:
- To investigate the influence of race on outcomes for patients experiencing cardiogenic shock.
- To identify potential disparities in the management and outcomes of cardiogenic shock across different racial groups.
Main Methods:
- A retrospective cohort study analyzed 2458 adult patients admitted for cardiogenic shock between June 2019 and June 2023.
- Patients were categorized into White, Black, and other racial groups for comparative analysis.
- Propensity score weighting was employed to compare mortality, length of stay, and mechanical support use.
Main Results:
- Black patients were younger, had higher Sequential Organ Failure Assessment scores, and were more likely to be admitted from inpatient wards.
- No significant differences in hospital or cardiac intensive care unit mortality were observed between racial groups.
- Black patients experienced significantly longer hospital and cardiac intensive care unit stays compared to White patients.
Conclusions:
- While mortality rates were similar, longer lengths of stay for Black patients suggest potential disparities in clinical management.
- Further research is needed to address and rectify inequities in cardiogenic shock care.
- These findings underscore the importance of examining race in cardiovascular outcomes research.
Background:
Race influences outcomes in patients with cardiovascular diseases. However, the impact of race on cardiogenic shock outcomes is unclear.
Methods:
This retrospective cohort study included adult patients admitted to a cardiac intensive care unit for cardiogenic shock from June 2019 through June 2023. For analysis, patients were divided into 3 racial groups: White, Black, and other. Baseline demographics, comorbidities, admission source, and Sequential Organ Failure Assessment scores were collected. Primary outcomes were hospital and cardiac intensive care unit mortality. Secondary outcomes were hospital and cardiac intensive care unit lengths of stay and temporary mechanical circulatory support use. Propensity score weighting was used; pairwise comparisons between each group were performed.
Results:
The analysis included 2458 patients (1959 White, 327 Black, 172 other). Black patients were younger, were less likely to be admitted from the emergency department (and more likely to be admitted from inpatient wards), and had higher Sequential Organ Failure Assessment scores than patients in the other 2 groups. Propensity-weighted pairwise comparisons demonstrated no significant differences in hospital and cardiac intensive care unit mortality. However, Black patients had significantly longer hospital (incidence rate ratio, 1.31; P < .001) and cardiac intensive care unit (incidence rate ratio, 1.33; P = .03) stays than did White patients but not patients in the "other" group. Temporary mechanical circulatory support use did not differ among groups.
Conclusions:
The results highlight disparities in clinical management of cardiogenic shock and the need for further research to address these inequities.
More Related Videos
Related Concept Videos
Cardiopulmonary Resuscitation IV: Pharmacological Management
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure I: Introduction

